Sood AK - Search Results

1

Dual targeting of EphA2 and FAK in ovarian carcinoma.

Shahzad MM, Lu C, Lee JW, Stone RL, Mitra R, Mangala LS, Lu Y, Baggerly KA, Danes CG, Nick AM, Halder J, Kim HS, Vivas-Mejia P, Landen CN, Lopez-Berestein G, Coleman RL, Sood AK. Shahzad MM, et al. Among authors: sood ak. Cancer Biol Ther. 2009 Jun;8(11):1027-34. doi: 10.4161/cbt.8.11.8523. Epub 2009 Jun 24. Cancer Biol Ther. 2009. PMID: 19395869 Free PMC article.

2

p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.

Sood AK, Coffin J, Jabbari S, Buller RE, Hendrix MJ, Klingelhutz A. Sood AK, et al. Cancer Biol Ther. 2002 Sep-Oct;1(5):511-7. doi: 10.4161/cbt.1.5.167. Cancer Biol Ther. 2002. PMID: 12496479 Free article.

3

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2002 Nov-Dec;1(6):661-4. doi: 10.4161/cbt.316. Cancer Biol Ther. 2002. PMID: 12642690 Free article.

4

The complexity of tumor vascularity.

Sood AK, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2003 May-Jun;2(3):257-8. Cancer Biol Ther. 2003. PMID: 12878860 No abstract available.

5

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA, Buller RE. Geisler JP, et al. Among authors: sood ak. Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770. Cancer. 2003. PMID: 14601090 Free article.

6

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: sood ak. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

7

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ. Sood AK, et al. Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6. Am J Pathol. 2004. PMID: 15466376 Free PMC article.

8

Genomic instability is associated with lack of telomerase activation in ovarian cancer.

Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK. Landen CN, et al. Among authors: sood ak. Cancer Biol Ther. 2004 Dec;3(12):1250-3. doi: 10.4161/cbt.3.12.1235. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477760 Free article.

9

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Sood AK, et al. Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013. Gynecol Oncol. 2005. PMID: 15907981

10

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters